Found: 7
Select item for more details and to access through your institution.
Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 665, doi. 10.1111/apt.14478
- By:
- Publication type:
- Article
A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 5, p. 599, doi. 10.1038/clpt.2014.173
- By:
- Publication type:
- Article
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin.
- Published in:
- Journal of Viral Hepatitis, 2012, v. 19, n. 7, p. 488, doi. 10.1111/j.1365-2893.2011.01569.x
- By:
- Publication type:
- Article
A perspective on modelling hepatitis C virus infection J. Guedj et al. A perspective on modelling HCV infection.
- Published in:
- Journal of Viral Hepatitis, 2010, v. 17, n. 12, p. 825, doi. 10.1111/j.1365-2893.2010.01348.x
- By:
- Publication type:
- Article
Maximum Likelihood Estimation in Dynamical Models of HIV.
- Published in:
- Biometrics, 2007, v. 63, n. 4, p. 1198, doi. 10.1111/j.1541-0420.2007.00812.x
- By:
- Publication type:
- Article
HCV Kinetic Models and Their Implications in Drug Development.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2015, v. 4, n. 4, p. 231, doi. 10.1002/psp4.28
- By:
- Publication type:
- Article
Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2013, v. 2, n. 7, p. 1, doi. 10.1038/psp.2013.31
- By:
- Publication type:
- Article